Non-Small Cell Lung Carcinoma (NSCLC) Market is expected to reach US$ 21.40 Billion by 2033 | FMI
The global Non-Small Cell Lung Carcinoma (NSCLC) Market is expected to generate a market value of US$ 8.25 billion in 2023 and a market value of US$ 21.40 billion by 2033, with a CAGR of 10% from 2023 to 2033. The rising prevalence of non-small cell lung carcinoma (NSCLC) worldwide due to increased air pollution and smoking habits among people can be attributed to the growth of the non-small cell lung carcinoma (NSCLC) market. From 2017 to 2022, the market for non-small cell lung carcinoma (NSCLC) grew at a CAGR of 7.3%. Get Full Access @ https://www.futuremarketinsights.com/reports/non-small-cell-lung-carcinoma-nsclc-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Non-Small Cell Lung Carcinoma (NSCLC) market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming ...